SEEN & UNSEEN/ How much illness & death could be averted by limiting the FDA to safety, leaving efficacy to markets? pic.twitter.com/4QkUuCCMDN
— Robert Graboyes (@Robert_Graboyes) March 11, 2015
Killer drug approval lags
14 Mar 2015 Leave a comment
in economics of regulation, Sam Peltzman Tags: drug lags, Drug safety
Recent Comments